Comparative effects of the N-methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia

Experimental Neurology

Volumn 149, Issue 1, 1998, Pages 203-208

  Danielisová, Viera ^a   Chavko, Mikuláš ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Energy metabolism; Functional impairment; Ischemia reperfusion; Rabbits; Recovery

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIZOCILPINE; LACTIC ACID; LOMERIZINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADOLESCENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; FUNCTIONAL DISEASE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SPINAL CORD ISCHEMIA;

EID: 0031938415     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6680     Document Type: Article

References (35)

1. Anderson D. K., Means E. D., Waters T. R., Green E. S. Susceptibility of feline spinal cord energy metabolism to severe incomplete ischemia. Neurology. 33:1983;722-731.
2. Atkinson D. E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Br. J. Pharmacol. 7:1968;4030-4032.
3. Bickler P. E., Hansen B. M. Causes of calcium accumulation in rat cortical brain slices during hypoxia and ischemia: Role of ion channels and membrane damage. Brain Res. 665:1994;269-276.
4. Buchan A. M. Do NMDA antagonists protects against cerebral ischemia: Are clinical trials warranted. Cerebrovasc. Brain Metab. Rev. 2:1990;1-26.
5. Chavko M., Maršala J. Mechanism of Ischemic Damage of the Spinal Cord. 1993;Veda, Bratislava.
6. Chavko M., Kalinčaková K., Kluchová D., Nemoto E. Blood flow and electrolytes in spinal cord ischemia. Exp. Neurol. 112:1991;299-303.
7. Choi D. W., Koh J. Y., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J. Neurosci. 8:1988;185-196.
8. Danielisová V., Maršala M., Chavko M., Maršala J. Postischemic hypoxia improves metabolic and functional recovery of the spinal cord. Neurology. 33:1990;722-731.
9. Davidoff R. A., Graham L. T., Shank R. P. Changes in amino acid concentrations associated with loss of spinal interneurons. J. Neurochem. 14:1968;1025-1031.
10. Davies J., Watkins J. C. Role of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord. Exp. Brain Res. 49:1983;280-290.
11. Degirolami U., Zivin J. A. Neuropathology of experimental spinal cord ischemia in the rabbit. J. Neuropathol. Exp. Neurol. 41:1982;129-149.
12. Evans R. H., Watkins J. C. Specific antagonism of excitant amino acids in the isolated spinal cord of the neonatal rat. Eur. J. Pharmacol. 50:1978;123-129.
13. Faden A. I., Jacobs T. P., Smith M. T. Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia. J. Neurosurg. 60:1984;796-799.
14. Faden A. I., Salzman S. Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13:1992;29-35.
15. Folbergrová J., Ljunggren B., Norberg K., Siesjo B. K. Influence of complete ischemia on glycolytic metabolites, citric acid intermediates, and associated amino acids in the rat cerebral cortex. Brain Res. 80:1972;265-279.
16. Follis F., Miller K., Scremin O. U., Pett S., Kessler R., Wernly J. NMDA receptor blockade and spinal cord ischemia due to aortic cross-clamping in the rat model. Can. J. Neurol. Sci. 21:1994;227-232.
17. Gifford R. G., Monyer H., Christine C. W., Choi D. W. Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res. 506:1990;399-342.
18. Johnson S. H., Kraimer J. M., Graeber G. M. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits. Stroke. 24:1993;1547-1553.
19. Kaku D. A., Gifford R. G., Choi D. W. Neuroprotective effects of glutamate and antagonist and extracellular acidity. Science. 260:1993;1516-1518.
20. Kanazawa T., Morita T., Harada K., Iwamoto T., Ohtaka H., Sukamoto T., Ito K., Nurimoto S. Selective effect of KB-2796, a new calcium entry blocker, on cerebral circulation: A comparative study of the effects of calcium entry blockers on cerebral and peripheral arterial blood flows. J. Cerebrovasc. Pharmacol. 16:1990;430-437.
21. Kochhar A., Zivin J. A., Mazzarella V. Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia. J. Neurotrauma. 8:1991;175-186.
22. Lowry O. H., Passonneau J. V. A Flexible System of Enzymatic Analysis. 1972;Academic Press, New York. p. 146-275.
23. Martiniak J., Saganová K., Chavko M. Free and peptide-bound amino acids as indicators of ischemic damage of the spinal cord. J. Neuropathol. Exp. Neurol. 50:1991;73-81.
24. Meldrum B. Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:1990;27-57.
25. Miller R. J. Multiple calcium channels and neuronal function. Science. 235:1987;46-52.
26. 3. J. Neurosci. 5:1985;2909-2919.
27. 2. Neurology. 38:1988;1667-1673.
28. Siesjo B. K. Pathophysiology and treatment of focal cerebral ischemia. II. Mechanism of damage and treatment. J. Neurosurg. 77:1992;337-354.
29. Silver I. A., Erecinska M. Intracellular and extracellular changes of [Ca++] in hypoxia and ischemia in rat brain in vivo. J. Gen. Physiol. 95:1990;837-866.
30. Svensson L. G., Von Ritter C. M., Groeneveld H. T., Richards E. S., Hunter S. J. S., Robins M. F., Hinder R. A. Cross-clamping of the thoracic aorta: influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and superoxide dismutase on spinal cord blood flow and paraplegia in baboons. Ann. Surg. 204:1986;38-47.
31. Simpson R. K., Robertson C. S., Goodman J. C. Spinal cord ischemia-induced elevation of amino acids: Extracellular measurement with microdialysis. Neurochem. Res. 15:1990;635-639.
32. Tymianski M., Tator C. H. Normal and abnormal calcium homeostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery. 38:1996;1176-1195.
33. Uematsu D., Greenberg J. H., Hickey W. F. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke. 20:1989;1531-1537.
34. Yum S. W., Faden A. I. Comparison of the neuroprotective effects of theND. Arch. Neurol. 47:1990;277-284.
35. Zivin J. A., Degirolami U., Hurwitz E. L. Spectrum of neurological deficit in experimental CNS ischemia: A quantitative study. Arch. Neurol. 39:1982;408-412.